SRTA
Strata Critical Medical Stock Analysis
AI Rating
- Quality3/10
- Growth↑ 9/10
- Value↑ 5/10
SRTA Growth
- Revenue Y/Y↑ 32.10%
- EPS Y/Y↑ 264.71%
- FCF Y/Y↓ -161.67%
SRTA Profitability
- Gross margin ↑ 21.70%
- EPS margin↑ 18.50%
- ROIC 5Y↑ -8.76%
SRTA Risk
- Debt / Equity↓ 0.0
- Debt / FCF↓ 0.0
- Interest coverage↓ NA
Strata Critical Medical stock volatility is higher than the overall market. We give it a Great risk rating.